Stevenage Bioscience Catalyst is the UK’s first open innovation bioscience campus, pioneering a unique culture to drive early stage bioscience technology and company development. It is backed by £38m of funding from GlaxoSmithKline, the Wellcome Trust and the UK Government. Consisting of an incubator, an accelerator and a hub, covering 60,000 sq ft of laboratory, office and networking space, the independent facility houses a range of companies. Located on the GlaxoSmithKline Stevenage site, Stevenage Bioscience Catalyst is in the unique position of operating in proximity to the expertise and resources of a major pharmaceutical company, close to London and Cambridge.
No data available
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Stratagem IPM was formed in 1999 to respond to a developing need within the biotech industry for clear and decisive strategic Intellectual Property advice. From its original biotech foundation, Stratagem now has commercially trained IP experts with first-hand experience in many industries, working with a wide range of clients, from start-ups and SMEs to multi-national companies.
With a Head Office in Cambridge, we deliver a strategically different IP management service for our clients, operating as though we are part of their business and using our hands-on management approach to ensure they are able to protect, exploit, and enhance the value of their IP assets and portfolios. We are dedicated to providing comprehensive intellectual property advice in the UK and internationally.
With a Head Office in Cambridge, we deliver a strategically different IP management service for our clients, operating as though we are part of their business and using our hands-on management approach to ensure they are able to protect, exploit, and enhance the value of their IP assets and portfolios. We are dedicated to providing comprehensive intellectual property advice in the UK and internationally.
Symbiosis IP is a patent attorney and professional services firm primarily serving the life science industry. We have a wealth of experience in working closely with corporate clients, start-up companies and academic institutions. This experience enables us to protect, develop and commercialise IP that drives new businesses forward whatever their complexity. Our team of patent attorneys all have higher degrees in a Life Science or chemical subject, and we all have post-doctoral research experience which we believe adds value to our clients’ intellectual property. In addition to prosecution of patent applications Symbiosis’ attorneys have direct experience of opposition and appeal proceedings. Our team of IP and innovation experts can support every aspect of IP commercialisation, including strategy, policy review and benchmarking, patent landscaping, market assessment, technology marketing, IP valuation, and licensing & transaction support. We are a trusted, independent partner and our team includes highly experienced ex-industry, university technology transfer and IP specialists with a wealth of real hands-on experience, global contacts and practical consulting experience. Together, our priority is to develop long-lasting, mutually beneficial professional relationships that maximise the benefit that your technology can bring to your business. Visit our website: https://www.symbiosisip.co.uk